Patent · US Active

Methods for overcoming glucocorticoid resistance and for determining glucocorticoid resistance potential in cancer

US11946053B2 · kind B2 · utility

0Cited by
1References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 2, 2019
Grant dateApr 2, 2024
Priority date
Expiry dateAug 9, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides methods for overcoming glucocorticoid resistance of cancers by inhibition of CASP1. Also disclosed are diagnostic methods for determining glucocorticoid resistance potential by measuring expression level or promoter methylation status of CASP1 gene and/or NLRP3 gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.